All In Biotech

Drug Trial Radar · NCT00057356

Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure

A Randomized, Double-blind, Placebo-controlled, Dose-ranging Pilot Study Evaluating the Efficacy and Safety of YM087 in Patients With Decompensated Chronic Heart Failure

Last checked: Nov 19, 2026Latest source record: May 2, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 170 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

170

Actual

Start

Nov 2002

Primary completion

Mar 2004

Study completion Mar 2004

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 1, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine the effects of conivaptan in patients with acute decompensated heart failure.

Conditions

  • Chronic Heart Failure

Interventions

  • conivaptanDrug

    IV

  • placeboDrug

    IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in respiratory Visual analog Scale (VAS)Time frame: 48 hours

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • The Heart Center, P.C.

    Huntsville, Alabama

  • LA County/USC Medical Center

    Los Angeles, California

  • San Joaquin Cardiology

    Manteca, California

  • Apex Research Institute

    Santa Ana, California

  • The Greater Fort Lauderdale Heart Group Research

    Fort Lauderdale, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • U. Miami, Jackson Mem'l Medical Center

    Miami, Florida

  • Discovery Medical Research Group

    Ocala, Florida

  • Rush-Presbyterian St. Luke's Medical Center

    Chicago, Illinois

  • Louisiana State University Medical Center School of Medicine

    New Orleans, Louisiana

  • New Orleans Center for Clinical Research

    New Orleans, Louisiana

  • Cardiac Centers of Louisiana, LLC

    Shreveport, Louisiana

  • University of Maryland Hospital

    Baltimore, Maryland

  • Hennepin County Medical Center

    Minneapolis, Minnesota

  • Washington University

    St Louis, Missouri

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire

  • New York Presbyterian Hosp, Milstein Hosp.

    New York, New York

  • University of Cincinnati, College of Medicine, Div. of Cardiology

    Cincinnati, Ohio

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • Ohio State University Medical Center, Heart and Lung Research Institute

    Columbus, Ohio

  • Hershey Medical Center

    Hershey, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • Baptist Clinical Research

    Memphis, Tennessee

  • Cardiovascular Research Institute of Dallas

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • University of Washington

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.